Program seeks to optimize appropriate use of antibiotics

Relying on a core team of physicians and pharmacists, the Vanderbilt Antimicrobial Stewardship Program (VASP) is seeking to ensure optimum use of antibiotics and other antimicrobial drugs at Vanderbilt University Medical Center (VUMC).

Study details rare heart risk of certain cancer therapies

Iadecola set for Oates Lectureship in Clinical Pharmacology

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.

Study finds natural compound extends lifespan of worms

A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.

Forum celebrates VUMC translational research expertise

Vanderbilt University Medical Center’s vibrant culture of clinical and translational research was celebrated at an annual forum last week, and two physician-scientist leaders were honored with awards.

VICC trial putting lung cancer therapy to the test

Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.